Denomme Gregory A, Wagner Franz F, Fernandes Bernard J, Li Wei, Flegel Willy A
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
Transfusion. 2005 Oct;45(10):1554-60. doi: 10.1111/j.1537-2995.2005.00586.x.
The D antigen includes category D, partial D, and weak D types, which are important because anti-D alloimmunization can occur in some but not all persons that express a variant RHD allele. At present, there is little prospective information on the prevalence of D variants among obstetric patients and potential transfusion recipients.
The RHD alleles were prospectively examined in a large patient population identified on the basis of a difference in anti-D reactivity between two reagents.
Fifty-five discrepancies (0.96% of D-) were noted among 33,864 ethnically diverse patients over 18 months, of which 54 represented mutated RHD alleles. Seven obstetric patients were assigned D- status based on serology; only 1 patient had a partial RHD allele. Ten of 25 (36%) obstetric patients and 4 of 6 (67%) female potential transfusion recipients of childbearing age or younger were assigned D+ status, and they expressed a D variant known to permit anti-D alloimmunization. In total 20 RHD alleles were identified including category, DVa or DVa-like alleles (n = 7), DAR (n = 8), and four novel RHD alleles including two new DAU alleles.
Given the complexity of D antigen expression, it is concluded that some clinically important D variants identified by standard serologic analysis phenotype as D+ and are potentially at risk for the development of anti-D.
D抗原包括D类别、部分D和弱D型,其重要性在于某些但并非所有表达变异RHD等位基因的个体可能发生抗-D同种免疫。目前,关于产科患者和潜在输血受者中D变异体患病率的前瞻性信息较少。
基于两种试剂之间抗-D反应性的差异,对一大群患者进行前瞻性RHD等位基因检测。
在18个月内对33,864名不同种族的患者进行检测,发现55例差异(占D-的0.96%),其中54例代表RHD等位基因突变。7名产科患者根据血清学被判定为D-状态;只有1例患者有部分RHD等位基因。25名产科患者中有10例(36%)以及6名育龄或更年轻的女性潜在输血受者中有4例(67%)被判定为D+状态,且她们表达已知可导致抗-D同种免疫的D变异体。总共鉴定出20种RHD等位基因,包括D类别、DVa或DVa样等位基因(n = 7)、DAR(n = 8)以及4种新的RHD等位基因,包括2种新的DAU等位基因。
鉴于D抗原表达的复杂性,得出结论:一些通过标准血清学分析表型为D+的临床上重要的D变异体可能有发生抗-D的风险。